Table 4. Antifungal susceptibility of the Cryptococcus gattii molecular type VGIII isolates by serotype.
MIC (μg/ml) | ||||
---|---|---|---|---|
Serotype | Range | MIC50 | MIC90 | Geometric mean |
Amphotericin B (p = 0.1153) | ||||
Serotype B | ≤0.125–1 | 0.25 | 0.5 | 0.2980 |
Serotype C | ≤0.125–2 | 0.25 | 0.5 | 0.2691 |
5-Flucytosine (p = 0.0397)* | ||||
Serotype B | 0.5–8 | 2 | 4 | 2.095 |
Serotype C | 0.5–4 | 2 | 4 | 1.580 |
Posaconazole (p < 0.0001)**** | ||||
Serotype B | 0.015–0.25 | 0.06 | 0.125 | 0.05698 |
Serotype C | 0.03–0.25 | 0.125 | 0.125 | 0.09445 |
Voriconazole (p < 0.0001)**** | ||||
Serotype B | ≤0.008–1 | 0.03 | 0.06 | 0.03304 |
Serotype C | ≤0.008–0.5 | 0.06 | 0.125 | 0.06346 |
Itraconazole (p = 0.0031)** | ||||
Serotype B | ≤0.015–0.25 | 0.03 | 0.125 | 0.03830 |
Serotype C | ≤0.015–2 | 0.06 | 0.125 | 0.06068 |
Fluconazole (p < 0.0001)**** | ||||
Serotype B | 1–128 | 4 | 8 | 3.927 |
Serotype C | 1–128 | 8 | 32 | 8.239 |
Statistical significance * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 and **** p ≤ 0.0001